- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04017884
Evaluation of Remin Pro Forte Versus Remin Pro on Treatment of White Spot Lesions Post Orthodontic Treatment
Evaluation of Caries Regression, Color Improvement and Mineral Content of White Spot Lesions Post-orthodontic Treatment After Remineralization With Remin Pro Forte Versus Remin Pro: A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recently, a remineralizing water based cream containing Hydroxyapatite, Fluoride and Xylitol (Remin pro) has been introduced. It has been claimed that hydroxyapatite fills eroded enamel, fluoride seals dentinal tubules and xylitol acts as an antibacterial agents. This product has been assumed to be suitable for management of dentinal hypersensitivity, prevention of enamel demineralization and promoting remineralization of enamel subsurface lesions. There are few studies regarding the effect of calcium phosphate and hydroxyapatite-based agents on remineralization and optical appearance of White spot lesions following orthodontic therapy.
Recently a new formulation of Remin pro has been introduced called (Remin Pro Forte) with the same components of fluoride, hydroxyapatite, xylitol in addition to two natural products (Ginger, curcuma) with the rationale based behind that they have antibacterial effect against streptococcus mutans in addition to anti-cariogenic effect which is being confirmed in the scientific literature.
Follow up period is selected to be 3 months, which is enough for evaluation of the outcomes (caries regression, color change, mineral content) assessed in this study.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- No systemic disease.
- Has completed fixed orthodontic treatment, brackets debonded.
- Has at least two teeth with white spot lesion.
- Has received conventional periodontal therapy after orthodontic treatment.
- Between the ages of 12 and 25 years of age.
Exclusion Criteria:
- Presence of enamel hypoplasia or dental fluorosis.
- Presence of tetracycline pigmentation.
- Periodontal pocketing of 3mm or greater.
- Taking antibiotics.
- Presence of carious cavities.
- Allergy to fluoride gel / varnish being used in study.
- Subjects who had evidence of reduced salivary flow or significant tooth wear
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Remin Pro Forte.
intervention
|
a combination of chemicals
|
|
Active Comparator: Remin pro.
comparator
|
a combination of chemicals with natural products cream .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
caries regression
Time Frame: 3 months
|
The assessment will be done by photographic image records and performing ICDAS II scoring on white spot lesions on the image records.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
color improvement
Time Frame: 3 months
|
To assess the color improvement of white spot lesions, Digital photographs of the white spot lesions will be taken using digital camera.
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mineral content
Time Frame: 3 months
|
To measure the mineral content of WSLs, the labial surfaces of the selected teeth will be assessed by VistaCam iX using a special head for taking fluorescent images according to the manufacturer's instructions.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: mennatallah aboulnaga, MD, Cairo University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PHD-CU-2019-07-10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesion
-
Future University in EgyptNot yet recruitingWhite Spot Lesion
-
Mansoura UniversityActive, not recruiting
-
Jordan University of Science and TechnologyActive, not recruitingWhite Spot Lesion of ToothJordan
-
King Abdullah University HospitalJordan University of Science and TechnologyActive, not recruitingWhite Spot LesionJordan
-
Al-Azhar UniversityEnrolling by invitation
-
Texas A&M UniversityCompletedWhite Spot LesionUnited States
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Cairo UniversityNot yet recruiting
-
Universitat Internacional de CatalunyaCompleted
-
EgymedicalpediaCompleted
Clinical Trials on Remin Pro
-
Al-Azhar UniversityCompletedWhite Spot Lesion of ToothEgypt
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Hacettepe UniversityActive, not recruiting
-
Universidad Autonoma de San Luis PotosíCompleted
-
Al-Azhar UniversityUnknown
-
The University of Texas Medical Branch, GalvestonCompletedDiet | Protein | Skeletal MuscleUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)Completed
-
CytoDyn, Inc.WEP ClinicalAvailableTNBC, Triple Negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | TNBCUnited States
-
United States Army Research Institute of Environmental...Eastern Michigan UniversityCompletedWeight Loss | Other Effects of High AltitudeUnited States
-
North Florida Foundation for Research and EducationPfizer; US Department of Veterans AffairsUnknownRheumatoid ArthritisUnited States